UBFD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.837000E-01
Normal-vs-Stage2
8.130000E-01
Normal-vs-Stage3
1.089040E-01
Normal-vs-Stage4
4.212000E-01
Stage1-vs-Stage2
5.988800E-01
Stage1-vs-Stage3
1.381970E-02
Stage1-vs-Stage4
5.131400E-01
Stage2-vs-Stage3
6.155900E-02
Stage2-vs-Stage4
1.926970E-01
Stage3-vs-Stage4
9.326500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.022600E-01
Normal-vs-AfricanAmerican
4.668800E-01
Normal-vs-Asian
6.959400E-01
Caucasian-vs-AfricanAmerican
4.894200E-01
Caucasian-vs-Asian
2.079600E-01
AfricanAmerican-vs-Asian
1.925400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.875200E-01
Normal-vs-Female
8.386200E-01
Male-vs-Female
7.877600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.925000E-01
Normal-vs-Age(41-60Yrs)
2.969400E-01
Normal-vs-Age(61-80Yrs)
9.202000E-01
Normal-vs-Age(81-100Yrs)
8.563400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.008600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.440000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.495400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.019870E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.703900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.547000E-01
Normal-vs-Daily Drinker
9.534800E-01
Normal-vs-Weekly Drinker
8.023800E-01
Normal-vs-Occasional Drinker
4.392000E-01
Normal-vs-Social Drinker
3.905400E-01
Non Drinker-vs-Daily Drinker
5.983000E-01
Non Drinker-vs-Weekly Drinker
8.485400E-01
Non Drinker-vs-Occasional Drinker
2.704400E-02
Non Drinker-vs-Social Drinker
4.286000E-02
Daily Drinker-vs-Weekly Drinker
7.785600E-01
Daily Drinker-vs-Occasional Drinker
1.004820E-01
Daily Drinker-vs-Social Drinker
1.390370E-01
Weekly Drinker-vs-Occasional Drinker
7.640400E-02
Weekly Drinker-vs-Social Drinker
7.452500E-02
Occasional Drinker-vs-Social Drinker
7.878000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.073600E-01
Normal-vs-Grade 2
6.433800E-02
Normal-vs-Grade 3
8.424000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.700600E-01
Grade 1-vs-Grade 3
6.709900E-02
Grade 1-vs-Grade 4
2.073600E-01
Grade 2-vs-Grade 3
1.430550E-01
Grade 2-vs-Grade 4
6.433800E-02
Grade 3-vs-Grade 4
8.424000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.011600E-01
Normal-vs-NonDiabetic
7.713000E-01
Diabetic-vs-NonDiabetic
4.123600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.853400E-01
Normal-vs-NoPancreatitis
9.177000E-01
Pancreatitis-vs-NoPancreatitis
1.187810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.915200E-01
Normal-vs-N1
7.767600E-01
N0-vs-N1
5.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.555200E-01
Normal-vs-TP53-NonMutant
9.786800E-01
TP53-Mutant-vs-TP53-NonMutant
1.122230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
